This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

IntriCon Reports 2011 Fourth-Quarter And Full-Year Results

Stocks in this article: IIN

IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its fourth quarter and year ended December 31, 2011.

For the 2011 fourth quarter, the company reported net sales of $14.5 million, consistent with net sales of $14.5 million for the prior-year period. IntriCon reported a net loss in the 2011 fourth quarter of $352,000, or $0.06 per diluted share, compared to a net loss of $169,000, or $0.03 per diluted share, for the prior-year fourth quarter.

“2011 was a year of significant investment in core technology development, global manufacturing infrastructure and specific program initiatives, most notably hi HealthInnovations,” said Mark S. Gorder, president and chief executive officer of IntriCon. “We believe we have set the stage for sustained growth in 2012 and beyond. We fully expect to see the benefits of our initiatives in the near and long term.

“Looking at our business as a whole, economic softness is leveling off and we’re starting to deliver sequential financial improvement. Medical revenues posted double-digit gains over the prior-year fourth quarter and we’re beginning to see the top-line impact of our hi HealthInnovations work.

“We believe that these trends, combined with the fact that we continue to invest in pipeline-building core technologies, position us well for the future. We’re helping companies reduce their costs by shifting the point of care from more expensive settings, like hospitals and clinics, to less expensive ones, such as the home or Internet, and meeting the growing demand for small and lightweight, advanced body-worn medical devices that connect patients and caregivers in non-traditional ways.”

Fourth-Quarter ResultsFourth-quarter medical sales increased 14.3 percent over the prior year, benefiting from rising sales to Medtronic and other key medical customers. Hearing health revenue declined 6.8 percent from the prior-year fourth quarter. This was primarily due to overall hearing health industry softness, partially offset by initial revenues from hi HealthInnovations. Professional audio communications sales were down 10 percent from the prior-year fourth quarter chiefly due to softness in various international niche markets.

Said Gorder, “Our work with hi HealthInnovations started to slowly ramp up in the fourth quarter, and this helped to mitigate declines in our traditional hearing health markets. We expect this ramp to continue in the 2012 first quarter. Moreover, we have a technically advanced product line with our innovative digital signal processing (DSP) circuits, such as our nanoDSP, Overtus™ DSP Amplifier, and complete systems such, as our APT™ and Lumen™. We anticipate these lines contributing to future growth in the traditional hearing health business, as this market rebounds.

1 of 5

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs